BioMarin Buys Preferred Shares of La Jolla Pharma

BioMarin Pharmaceutical Inc. received 339,104 shares of La Jolla Pharmaceutical Co. preferred stock — potentially convertible into nearly 10.2 million shares of common stock — as part of the companies’ recent development and commercialization deal.
San Francisco Business Times